We investigated the efficacy, safety, and versatility of the AngioVac (AngioDynamics,
Latham, NY) system for the treatment of intravascular and intracardiac masses of different …

Die interventionelle Therapie der akuten Lungenembolie bietet großes Potenzial zur
Senkung von Morbidität und Mortalität ausgewählter Patientinnen und Patienten mit …

OBJECTIVES The presence of right heart thrombi in transit (RHTiT) in the setting of acute
pulmonary embolism (PE) is associated with high mortality. The optimal management in …

BACKGROUND: The role of advanced therapies (systemic thrombolysis, catheter-based
treatment, and surgical thrombectomy) for the management of right heart thrombus is poorly …

Background Aspiration thrombectomy devices, such as the AngioVac, allow the removal of
thrombus, especially in patients with contraindications to anticoagulation use. The AngioVac …

Abstract Introduction The AngioVac system is a novel, minimally invasive, endovascular
technique used to evacuate intravascular or intracardiac vegetation or thrombus. Although …

Introduction Right‐side infective endocarditis (RSIE) is caused by microorganisms and
develops into intracardiac and extracardiac complications with high in‐hospital and 1‐year …

Clot in transit (CIT) is a rare condition in which a venous thromboembolism becomes lodged
in the right heart. It is seen in up to 18% of patients with massive pulmonary embolism, and if …

Background: Thrombotic material in the non-aneurysmatic and non-atherosclerotic aorta is a
rare entity without any recommended standard treatment so far. We present a successful …

Abstract The AngioVac© system (AngioDynamics, Latham, NY, USA) is a percutaneous
catheter-based approach indicated for the removal of unwanted intravascular material from …